Cv Sciences Inc (CVSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,418 | -643 | -958 | -752 | -370 |
| Depreciation Amortization | 267 | 179 | 705 | 732 | 531 |
| Income taxes - deferred | N/A | N/A | 3 | N/A | N/A |
| Accounts receivable | 66 | 22 | 124 | 130 | -12 |
| Accounts payable and accrued liabilities | N/A | N/A | -1,342 | -1,076 | N/A |
| Other Working Capital | 288 | 197 | -470 | 25 | 250 |
| Other Operating Activity | 918 | 346 | 1,531 | 888 | -193 |
| Operating Cash Flow | $121 | $101 | $-407 | $-53 | $206 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -3 | -109 | -100 | -89 |
| Investing Cash Flow | $-10 | $-3 | $-109 | $-100 | $-89 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,650 | 1,200 | 1,200 |
| Other Financing Activity | -122 | -68 | -1,313 | -1,121 | -887 |
| Financing Cash Flow | $-122 | $-68 | $337 | $79 | $313 |
| Exchange Rate Effect | -1 | 1 | 3 | 1 | 2 |
| Beginning Cash Position | 278 | 278 | 454 | 454 | 454 |
| End Cash Position | 266 | 309 | 278 | 381 | 886 |
| Net Cash Flow | $-12 | $31 | $-176 | $-73 | $432 |
| Free Cash Flow | |||||
| Operating Cash Flow | 121 | 101 | -407 | -53 | 206 |
| Capital Expenditure | -10 | -3 | -109 | -100 | -89 |
| Free Cash Flow | 111 | 98 | -516 | -153 | 117 |